Clinical trial
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
NCT01420393 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- June 30, 2021
- Enrollment
- 411 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.